Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas - PubMed (original) (raw)

. 2005 Jan 1;11(1):267-72.

Affiliations

PMID: 15671555

Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas

Amy B Heimberger et al. Clin Cancer Res. 2005.

Abstract

Purpose: The activator protein (AP)-2alpha transcription factor plays a crucial role in the progression of several human tumors, including malignant melanoma, prostate, and breast cancer. Loss of AP-2alpha results in deregulation of several genes with AP-2alpha binding motifs such as E-cadherin, p21WAF1, MMP-2, MCAM/MUC18, VEGF, and c-KIT. The purpose of our study was to determine AP-2alpha expression distribution among grades of gliomas and any possible effect on prognosis.

Experimental design: A tissue microarray was assembled from all surgical glioma cases with available tissue samples at M.D. Anderson Cancer Center since 1986 to include 72 glioblastomas, 49 anaplastic astrocytomas, 9 low-grade astrocytoma, 37 oligodendrogliomas, 37 anaplastic oligodendrogliomas, 15 mixed oligoastrocytomas, 20 anaplastic mixed oligoastrocytomas, and 7 gliosarcomas. The microarray included normal brain tissue, and AP-2alpha expression was determined by immunohistochemistry.

Results: AP-2alpha expression was lost on 99% (P < 0.001) and 98% (P < 0.001) of glioblastomas and anaplastic astrocytomas, respectively, compared with grade 2 astrocytomas and normal brain, all of which (100%) maintained expression of AP-2alpha. The loss of AP-2alpha was a negative prognostic indicator within the overall category of gliomas by univariate analysis (rate ratio, 4.30; 95% confidence interval, 2.60-7.10; P < 0.001). However, there was no significant effect of loss of AP-2alpha expression on survival observed after adjustment for patient age, Karnofsky Performance Scale score, tumor grade, and extent of resection (rate ratio, 1.2; 95% confidence interval, 0.6-2.2; P = 0.6).

Conclusions: AP-2alpha expression correlates inversely with glioma grade, suggesting a direct role in glioma tumorigenicity, possibly through subsequent deregulation of target genes. Of all the previously characterized markers of progression, the loss of AP-2alpha would be the most common (96.2%) molecular marker as an astrocytic tumor evolves from grade 2 to 3.

PubMed Disclaimer

Cited by

Cancer stem cells from a rare form of glioblastoma multiforme involving the neurogenic ventricular wall.
Li SC, Vu LT, Ho HW, Yin HZ, Keschrumrus V, Lu Q, Wang J, Zhang H, Ma Z, Stover A, Weiss JH, Schwartz PH, Loudon WG. Li SC, et al. Cancer Cell Int. 2012 Sep 20;12(1):41. doi: 10.1186/1475-2867-12-41. Cancer Cell Int. 2012. PMID: 22995409 Free PMC article.
n-Butylidenephthalide induced apoptosis in the A549 human lung adenocarcinoma cell line by coupled down-regulation of AP-2alpha and telomerase activity.
Wei CW, Lin CC, Yu YL, Lin CY, Lin PC, Wu MT, Chen CJ, Chang W, Lin SZ, Chen YL, Harn HJ. Wei CW, et al. Acta Pharmacol Sin. 2009 Sep;30(9):1297-306. doi: 10.1038/aps.2009.124. Epub 2009 Aug 24. Acta Pharmacol Sin. 2009. PMID: 19701232 Free PMC article.
Aurora-A interacts with AP-2α and down regulates its transcription activity.
Zou L, Sun Y, Wang M, Zhan Q. Zou L, et al. PLoS One. 2011;6(8):e23110. doi: 10.1371/journal.pone.0023110. Epub 2011 Aug 1. PLoS One. 2011. PMID: 21829699 Free PMC article.
WWOX Loses the Ability to Regulate Oncogenic AP-2γ and Synergizes with Tumor Suppressor AP-2α in High-Grade Bladder Cancer.
Kołat D, Kałuzińska Ż, Bednarek AK, Płuciennik E. Kołat D, et al. Cancers (Basel). 2021 Jun 12;13(12):2957. doi: 10.3390/cancers13122957. Cancers (Basel). 2021. PMID: 34204827 Free PMC article.
A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance.
Wu Y, Xiao Y, Ding X, Zhuo Y, Ren P, Zhou C, Zhou J. Wu Y, et al. PLoS One. 2011;6(12):e29043. doi: 10.1371/journal.pone.0029043. Epub 2011 Dec 14. PLoS One. 2011. PMID: 22194984 Free PMC article.

Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas - PubMed (original) (raw)